SPRC
SPRC
NASDAQ · Pharmaceuticals

Scisparc Ltd

$6.92
-0.05 (-0.72%)
As of Jun 23, 10:22 PM ET ·
Financial Highlights (FY 2026)
Revenue
12.09M
Net Income
-171,958,772
Gross Margin
73.7%
Profit Margin
-1,422.8%
Rev Growth
-14.1%
D/E Ratio
0.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 73.7% 73.7% 57.0% 57.0%
Operating Margin -978.3% -880.4% 34.2% 35.2%
Profit Margin -1,422.8% -1,351.6% 31.3% 33.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 12.09M 14.07M 1.35M 1.33M
Gross Profit 8.91M 10.37M 772.6K 759.7K
Operating Income -118,234,504 -123,863,407 463.6K 468.3K
Net Income -171,958,772 -180,145,378 424.2K 446.9K
Gross Margin 73.7% 73.7% 57.0% 57.0%
Operating Margin -978.3% -880.4% 34.2% 35.2%
Profit Margin -1,422.8% -1,351.6% 31.3% 33.6%
Rev Growth -14.1% -14.1% -3.8% +21.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 164.6K 164.6K 970.1K 740.6K
Total Equity 1.96M 1.96M 893.1K 867.5K
D/E Ratio 0.08 0.08 1.09 0.85
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -114,930,962 -127,091,623 830.6K 717.6K
Free Cash Flow 355.4K 299.5K